Reporter Staff
| This email address is being protected from spambots. You need JavaScript enabled to view it.
According to the National Highway Traffic Safety Administration, auto thefts are a continued concern nationwide—and not just the contents inside the cars, but the cars themselves. These habits can help maintain a secure environment.
Published in
Campus Safety
May 17, 2024
Geurs named new School of Dentistry dean
Nicolaas Geurs, D.D.S., M.S., inaugural holder of UAB's Weatherford-Palcanis Endowed Professorship in Dentistry and the Dental Alumni-Joseph F. Volker Chair of Clinical Dentistry, has been selected as the next dean of the UAB School of Dentistry following a national search. He will begin his new role June 1.
Published in
Leadership
May 16, 2024
Updates on FLSA changes coming soon
The U.S. Department of Labor has announced a change to the criteria for determining employees’ status as nonexempt (paid bi-weekly) or exempt (paid monthly) under the Fair Labor Standards Act. This is not a UAB decision; it is a federal law all employers must follow.
Published in
Take Note
May 08, 2024
UAB Police holds promotion ceremony
The UAB Police and Public Safety Department held its first promotional ceremony on Jan. 3, 2024, recognizing officers and employees who have moved up the ranks for their dedication and committed service to the UAB Community.
Published in
Campus Safety
May 03, 2024
Healthy Women Needed for a Research Study
You may be eligible to participate in a research study: If you are a healthy female, between age of 18-50, still having a regular menstrual cycle & you are NOT on hormonal birth control (birth control pills or shots (i.e. Depo shot) or IUD, like Mirena). And, if you are willing to undergo an endometrial biopsy procedure and blood draw. Participants will be compensated a total of $200. Only requires 2 visits.
For information, call us at 205-934-5498 or email Stephanie Ford at smford@uabmc.edu
For information, call us at 205-934-5498 or email Stephanie Ford at smford@uabmc.edu
Published in
Clinical Trials
On May 6, join a virtual 30-minute session exploring the Career Goals feature in LinkedIn Learning, an online learning resource platform available at no cost to all benefit-eligible employees at UAB. Register today.
Published in
Learning & Development
A Phase 3, Randomized, Multicenter, Open-label Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly Compared with Semaglutide Once Weekly in Adult Participants with Type 2 Diabetes and Inadequate Glycemic Control with Metformin with or without SGLT2 Inhibitor (TRANSCEND-T2D-2)
TRANSCEND-T2D-2 is a clinical research study for people with type 2 diabetes.
This study will test if an investigational medicine (the medicine being studied) can
help with blood glucose (sugar) and weight management compared with an existing
treatment for type 2 diabetes.
- Are aged 18 years or older
- Have type 2 diabetes
- Have been taking 1500mg or more of metformin each day for at least 3 months (with or without SGLT2i)
- Have a BMI of 25 or more
- Have HbA1c levels of 7.0% to 10.5%
To see if you qualify please contact at 205-996-4015, 205-934-5564 or via mail at tthoma@uab.edu or ccnrn@uab.edu
Published in
Clinical Trials
April 29, 2024
UAB Learning & Development Learn to Win Challenge Returns
The Learn to Win challenge is a quarterly event that offers a curated learning path for UAB’s community of benefit-eligible learners. This quarter’s contest, “Learn to Win: Power Skills for Today and Tomorrow,” offers a chance to win prizes by completing a series of videos by May 31.
Published in
Learning & Development
April 24, 2024
Diagnosed with depression? Your mental health matters.
If you’ve been feeling stuck and longing for relief, you may be eligible to receive dedicated medical attention, an investigational therapeutic and compensation for your involvement in an innovative research study.
We're conducting clinical research in depression to learn how individuals’ brain biology impacts response to treatment, with the goal to help people find relief faster. You do not need to already have a diagnosis to participate.
If you’re currently taking medication, you are likely still eligible for our studies and don’t have to stop your existing treatment regimen.
For more information about this trial and to see if you qualify, please contact Kristine at kristinepike@uabmc.edu or 205-975-8542.
We're conducting clinical research in depression to learn how individuals’ brain biology impacts response to treatment, with the goal to help people find relief faster. You do not need to already have a diagnosis to participate.
If you’re currently taking medication, you are likely still eligible for our studies and don’t have to stop your existing treatment regimen.
For more information about this trial and to see if you qualify, please contact Kristine at kristinepike@uabmc.edu or 205-975-8542.
Published in
Clinical Trials
April 24, 2024
Are you currently or have you ever been depressed?
Major Depressive Disorder is a mental health condition characterized by periods of low mood, low self-esteem, and loss of interest or pleasure in normally enjoyable activities. The purpose of this clinical research study is to evaluate the safety and effectiveness of an investigational drug for Major Depressive Disorder, also known as Major Depression. Study participation may include several clinic visits over a period of up to 5 months with an opportunity to conduct some visits either virtually or in-clinic. Qualified participants will receive compensation for their time.
For more information about this trial and to see if you qualify, please contact Kristine at kristinepike@uabmc.edu or 205-975-8542.
For more information about this trial and to see if you qualify, please contact Kristine at kristinepike@uabmc.edu or 205-975-8542.
Published in
Clinical Trials
